Table: Immuno Biological Lab - 6-MTH group results
Nov 2 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2023 Sep 30, 2022 Mar 31, 2024
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 365 mln 293 mln 850 mln
(+24.7 pct) (+15.4 pct) (+7.0 pct)
Operating 14 mln loss 54 mln 90 mln
(+54.2 pct)
Recurring 30 mln loss 129 mln 90 mln
Net 26 mln loss 136 mln 80 mln
EPS 2.88 yen loss 14.62 yen 8.58 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T